Safety, Tolerability, and Immunogenicity of VARIVAX (2007 Commercial VZV Bulk Process) Administered Concomitantly With M-M-R II in Healthy Children 12-to-23 Months of Age.
Phase of Trial: Phase III
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Varicella zoster virus vaccine live (Primary) ; Measles mumps and rubella virus vaccine
- Indications Chickenpox; Measles; Mumps; Rubella
- Focus Pharmacodynamics
- Sponsors Merck & Co
- 19 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Nov 2009 Planned end date changed from 1 Mar 2010 to 1 Dec 2009 as reported by ClinicalTrials.gov.
- 09 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.